The Multiplicity of the D1 Dopamine Receptor
Data up to Jan 2025
Total Citations Per Year
Abstract
References (83)
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
1949 • 19,979 citations
Multiple receptors for dopamine
1979 • 3,739 citations
Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system
1970 • 1,980 citations
Isolated removal of hypothalamic or other brain nuclei of the rat
1973 • 1,421 citations
Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “dopamine receptor”
1972 • 1,022 citations
Phosphorylated Proteins as Physiological Effectors
1978 • 975 citations
SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
1983 • 886 citations
SCH 23390—The first selective dopamine D-1 antagonist
1983 • 738 citations
Adenosine receptors and behavioral actions of methylxanthines.
1981 • 705 citations
Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
1975 • 695 citations
Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum
1984 • 566 citations
Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity
1976 • 564 citations
The dopamine hypothesis of schizophrenia: focus on the dopamine receptor
1976 • 543 citations
Spiperone: A ligand of choice for neuroleptic receptors
1978 • 541 citations
Adenosine receptors in the central nervous system: Relationship to the central actions of methylxanthines
1981 • 535 citations
Dopamine Receptors in the Brain
1975 • 528 citations
Dopamine-Sensitive Adenylate Cyclase in Mammalian Brain: A Possible Site of Action of Antipsychotic Drugs
1974 • 450 citations
Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum
1978 • 401 citations
The Classification of Dopamine Receptors: Relationship to Radioligand Binding
1983 • 392 citations
Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics
1984 • 373 citations
Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
1983 • 355 citations
Cyclic Nucleotides in the Nervous System
1977 • 297 citations
[47] Isolation of synaptosomal and synaptic plasma membrane fractions
1974 • 295 citations
Stimulation by Dopamine of Adenylate Cyclase in Retinal Homogenates and of Adenosine-3′:5′-Cyclic Monophosphate Formation in Intact Retina
1972 • 286 citations
Regulatory peptides from molecular biology to function.
1982 • 263 citations
Effects of neuroleptics on 3H-haloperidol and 3H-CIS (Z)-flupenthixol binding and on adenylate cyclase activity in vitro
1978 • 261 citations
CNS receptors: From molecular pharmacology to behavior
1983 • 218 citations
Subcellular localization of dopamine-sensitive adenylate cyclase and dopamine receptor binding activities
1978 • 198 citations
Dopaminergic and Noradrenergic Substrates of Positive Reinforcement: Differential Effects of d - and l -Amphetamine
1973 • 197 citations
Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
1983 • 184 citations
Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.
1976 • 160 citations
SCH-23390: A selective D1 dopamine antagonist with potent D2 behavioral actions
1984 • 158 citations
Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography
1974 • 151 citations
Optimal Conditions for [3H]Apomorphine Binding and Anomalous Equilibrium Binding of [3H]Apomorphine and [3H]Spiperone to Rat Striatal Membranes: Involvement of Surface Phenomena Versus Multiple Binding Sites
1981 • 130 citations
Binding of [3H]SCH23390 in Rat Brain: Regional Distribution and Effects of Assay Conditions and GTP Suggest Interactions at a D1‐Like Dopamine Receptor
1985 • 116 citations
Effects of neurohumoral and adrenergic agents on cyclic amp levels in various areas of the rat brain in vitro
1973 • 112 citations
Graphical Methods in Enzyme Chemistry
1957 • 106 citations
Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra
1979 • 100 citations
Increase in dopamine metabolites in rat brain by neurotensin.
1982 • 99 citations
Effects of bromocriptine on central dopaminergic receptors
1976 • 98 citations
Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro
1981 • 98 citations
Effects of ergots on adenylate cyclase activity in the corpus striatum and pituitary
1977 • 97 citations
Recovery of beta-adrenergic receptors following long term exposure of astrocytoma cells to catecholamine. Role of protein synthesis.
1981 • 96 citations
Role of dopamine in d-amphetamine-induced discriminative responding
1975 • 85 citations
Characteristics of dopamine and β-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases
1977 • 81 citations
Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine
1976 • 73 citations
CNS receptors : from molecular pharmacology to behavior
1983 • 71 citations
Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390
1983 • 66 citations
[3H]SCH23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system
1984 • 55 citations
Radioreceptor assay of haloperidol tissue levels in the rat
1980 • 51 citations
Dopamine Receptors in the Central Nervous System
1982 • 51 citations
Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
1986 • 51 citations
The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.
1975 • 47 citations
SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
1986 • 46 citations
SCH23390 causes persistent antidopaminergic effects in vivo: Evidence for longterm occupation of receptors
1985 • 40 citations
Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine.
1984 • 40 citations
The Multiplicity of the D1 Dopamine Receptor
1986 • 38 citations
An Improved, Automated Adenylate Cyclase Assay Utilizing Preparative HPLC: Effects of Phosphodiesterase Inhibitors
1984 • 35 citations
Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
1984 • 34 citations
Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
1984 • 32 citations
Dopamine Receptors
1982 • 31 citations
Subcellular localization of dopamine-sensitive adenylate cyclase in rat brain striatum
1976 • 31 citations
Quantification of R-(+)-7-chloro-8-hydroxyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3-benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection
1985 • 30 citations
N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function.
1983 • 30 citations
Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
1979 • 28 citations
Distinction between dopaminergic and serotonergic components of neuroleptic binding sites in limbic brain areas
1979 • 28 citations
Dopaminergic 3H-agonist receptors in rat brain new evidence on localization and pharmacology
1984 • 27 citations
Metabolism, Distribution and Excretion of Flupenthixol
1969 • 27 citations
In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5, 6-ADTN
1983 • 25 citations
Beta adrenergic receptor-mediated adenosine cyclic 3',5'-monophosphate accumulation in the ratcorpus striatum.
1976 • 22 citations
Analytical Subcellular Fractionation of Rat Cortex: Resolution of Serotonergic Nerve Endings and Receptors
1983 • 22 citations
Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
1984 • 19 citations
Clinical relevance of dopamine receptor classification
1980 • 17 citations
In vivo dopamine receptor agonist binding in rat brain: Relation with pharmacological effects
1983 • 15 citations
Ascorbic acid decreases [3H]dopamine binding in striatum without inhibiting dopamine-sensitive adenylate cyclase
1984 • 14 citations
Modification of the amphetamine-induced stereotypy in rats following inhibition of the noradrenaline release by FLA 136
1977 • 11 citations
Comparison of the inhibitory effects of neuroleptic drugs on adenylate cyclase in rat tissues stimulated by dopamine, noradrenaline and glucagon
1976 • 11 citations
DOPAMINE RECEPTORS IN BRAIN
1984 • 9 citations
S(?)DP-5,6-ADTN as an in vivo dopamine receptor ligand: Relation between displacement by dopamine agonists and their pharmacological effects
1986 • 6 citations
Effect of catecholamines on locomotor activity and cyclic AMP in nucleus accumbens in rats
1983 • 6 citations
On the mechanism of inhibition of dopamine receptors by fluphenazine
1983 • 5 citations
In vivo dopamine receptor binding of a non-radioactively labelled agonist, dipropyl-5, 6-ADTN
1983 • 5 citations
DOPAMINE RECEPTOR MULTIPLICITY - WHEN THE D1-ANTAGONIST IS A D2-ANTAGONIST
1984 • 3 citations